Literature DB >> 11895092

Tattooing and risk for transfusion-transmitted diseases: the role of the type, number and design of the tattoos, and the conditions in which they were performed.

S de A Nishioka1, T W Gyorkos, L Joseph, J P Collet, J D Maclean.   

Abstract

Tattoos have been shown to be associated with transfusion-transmitted diseases (TTDs), particularly hepatitis B virus (HBV) and hepatitis C virus (HCV) infections. Very little is known about the association between different categories of tattoos and TTDs. In a cross-sectional study in Brazil, we studied 182 individuals with tattoos and assessed the odds of testing positive for a TTD according to tattoo type, number, design and performance conditions. Major findings were significant associations between an increasing number of tattoos and HBV infection (odds ratio (OR) of 2.04 for two tattoos and 3.48 for > or = 3 tattoos), having a non-professional tattoo and testing positive for at least one TTD (OR = 3.25), and having > or = 3 tattoos and testing positive for at least one TTD (OR = 2.98). We suggest that non-professional tattoos and number of tattoos should be assessed as potential deferral criteria in screening blood donors.

Entities:  

Mesh:

Year:  2002        PMID: 11895092      PMCID: PMC2869796          DOI: 10.1017/s0950268801006094

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  9 in total

Review 1.  Transmission of hepatitis C virus infection through tattooing and piercing: a critical review.

Authors:  Rania A Tohme; Scott D Holmberg
Journal:  Clin Infect Dis       Date:  2012-01-30       Impact factor: 9.079

2.  Prevalence, distribution, and correlates of hepatitis C virus infection among homeless adults in Los Angeles.

Authors:  Lillian Gelberg; Marjorie J Robertson; Lisa Arangua; Barbara D Leake; Gerald Sumner; Ardis Moe; Ronald M Andersen; Hal Morgenstern; Adeline Nyamathi
Journal:  Public Health Rep       Date:  2012 Jul-Aug       Impact factor: 2.792

Review 3.  Epidemiology of hepatitis C in Croatia in the European context.

Authors:  Tatjana Vilibic-Cavlek; Jasmina Kucinar; Bernard Kaic; Maja Vilibic; Nenad Pandak; Ljubo Barbic; Vladimir Stevanovic; Jasmina Vranes
Journal:  World J Gastroenterol       Date:  2015-08-28       Impact factor: 5.742

4.  Epidemiology of hepatitis B virus infection in first-time blood donors in the southwestern region of Goiás, central Brazil.

Authors:  Giulena Rosa Leite Cardoso Dos Anjos; Regina Maria Bringel Martins; Megmar Aparecida Dos Santos Carneiro; Sandra Maria Brunini; Sheila Araujo Teles
Journal:  Rev Bras Hematol Hemoter       Date:  2011

5.  Risk factors associated with Hepatitis C among female substance users enrolled in community-based HIV prevention studies.

Authors:  Diana Nurutdinova; Arbi B Abdallah; Susan Bradford; Catina C O'Leary; Linda B Cottler
Journal:  BMC Res Notes       Date:  2011-04-14

6.  People with multiple tattoos and/or piercings are not at increased risk for HBV or HCV in The Netherlands.

Authors:  Anouk T Urbanus; Anneke van den Hoek; Albert Boonstra; Robin van Houdt; Lotte J de Bruijn; Titia Heijman; Roel A Coutinho; Maria Prins
Journal:  PLoS One       Date:  2011-09-14       Impact factor: 3.240

7.  Factors Associated with Hepatitis C Infection among Chronic HCV Egyptian Patients.

Authors:  Ekram W Abd El-Wahab; Ashraf Mikheal; Fathallah Sidkey; Hanan Z Shatat
Journal:  Iran J Public Health       Date:  2014-11       Impact factor: 1.429

8.  Tattooing among Iranian prisoners: results of the two national biobehavioral surveillance surveys in 2015-2016.

Authors:  Saeede Jafari; Ghobad Moradi; Bushra Zareie; Mohammad Mehdi Gouya; Fatemeh Azimian Zavareh; Ebrahim Ghaderi
Journal:  An Bras Dermatol       Date:  2020-03-20       Impact factor: 1.896

9.  Tattoos on 18-year-old male adolescents--characteristics and associated factors.

Authors:  José Froner Bicca; Rodrigo Pereira Duquia; Juliano de Avelar Breunig; Paulo Ricardo Martins de Souza; Hiram Larangeira de Almeida
Journal:  An Bras Dermatol       Date:  2013 Nov-Dec       Impact factor: 1.896

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.